%0 Journal Article
%T Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials
%A Alexander El-Warrak
%A Alyssa Goldstein
%A Badru Moloo
%A Beta Yadollahi
%A Brian D. Lichty
%A Carole Evelegh
%A Caroline J. Breitbach
%A Chantal G. Martin
%A David F. Stojdl
%A David Hanwell
%A Galina Denisova
%A Gautier Stoll
%A J. Andrea McCart
%A Jamie Millar
%A John C. Bell
%A Jonathan G. Pol
%A Jonathan L. Bramson
%A Julia Pomoransky
%A Kyle B. Stephenson
%A Matthew J. Atherton
%A Nan Tang
%A Patricia V. Turner
%A Roberto Lopez
%A Robin Parsons
%A Sandra LaFrance
%A Sergio A. Acuna
%A Yonghong Wan
%J Archive of "Oncoimmunology".
%D 2019
%R 10.1080/2162402X.2018.1512329
%K Oncolytic vaccination
%K MG1 Maraba
%K MAGE-A3
%K Cancer immunotherapy
%K endogenous immunity
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287790/